Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (231-240 of 682) with videos related to

Pageof 69
Sort By:
The Journal of Antimicrobial Chemotherapy|February 10, 2018
Development of a dosing nomogram for continuous-infusion meropenem in critically ill patients based on a validated population pharmacokinetic modelIris K Minichmayr, Jason A Roberts, Otto R Frey, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
A Systematic Review of Studies Reporting Antibiotic Pharmacokinetic Data in the Cerebrospinal Fluid of Critically Ill Patients with Uninflamed MeningesNilesh Kumta, Jason A Roberts, Jeffrey Lipman, et al.
Antimicrobial Agents and Chemotherapy|April 7, 2022
Use of the Hollow-Fiber Infection Model to Measure the Effect of Combination Therapy of Septic Shock Exposures of Meropenem and Ciprofloxacin against Intermediate and Resistant Pseudomonas aeruginosa Clinical IsolatesNatalija Karabasevic, Jason A Roberts, Luke Stronach, et al.
Analytical and Bioanalytical Chemistry|November 17, 2019
A validated LC-MSMS method for the simultaneous quantification of meropenem and vaborbactam in human plasma and renal replacement therapy effluent and its application to a pharmacokinetic studySuzanne L Parker, Saurabh Pandey, Fekade B Sime, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 3, 2011
Pharmacokinetic evaluation of fluconazole in critically ill patientsMahipal Sinnollareddy, Sandra L Peake, Michael S Roberts, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2014
Comparison of the accuracy and precision of pharmacokinetic equations to predict free meropenem concentrations in critically ill patientsGloria Wong, Andras Farkas, Rachel Sussman, et al.
International Journal of Antimicrobial Agents|July 26, 2015
Population pharmacokinetics and dosing simulations of cefepime in septic shock patients receiving continuous renal replacement therapyMieke Carlier, Fabio S Taccone, Majorie Beumier, et al.
Drug Discovery Today|January 18, 2019
Solid nanoparticles for oral antimicrobial drug delivery: a reviewAun Raza, Fekade Bruck Sime, Peter J Cabot, et al.
Expert Review of Clinical Pharmacology|May 29, 2019
Antibiotic exposure at the site of infection: principles and assessment of tissue penetrationNynke G L Jager, Reinier M van Hest, Jeffrey Lipman, et al.
Clinical Therapeutics|August 22, 2016
Uncertainty in Antibiotic Dosing in Critically Ill Neonate and Pediatric Patients: Can Microsampling Provide the Answers?Tavey Dorofaeff, Rossella M Bandini, Jeffrey Lipman, et al.
Pageof 69

Showing results (231-240 of 682) with videos related to

Sort By:
Pageof 69
The Journal of Antimicrobial Chemotherapy|February 10, 2018
Development of a dosing nomogram for continuous-infusion meropenem in critically ill patients based on a validated population pharmacokinetic modelIris K Minichmayr, Jason A Roberts, Otto R Frey, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
A Systematic Review of Studies Reporting Antibiotic Pharmacokinetic Data in the Cerebrospinal Fluid of Critically Ill Patients with Uninflamed MeningesNilesh Kumta, Jason A Roberts, Jeffrey Lipman, et al.
Antimicrobial Agents and Chemotherapy|April 7, 2022
Use of the Hollow-Fiber Infection Model to Measure the Effect of Combination Therapy of Septic Shock Exposures of Meropenem and Ciprofloxacin against Intermediate and Resistant Pseudomonas aeruginosa Clinical IsolatesNatalija Karabasevic, Jason A Roberts, Luke Stronach, et al.
Analytical and Bioanalytical Chemistry|November 17, 2019
A validated LC-MSMS method for the simultaneous quantification of meropenem and vaborbactam in human plasma and renal replacement therapy effluent and its application to a pharmacokinetic studySuzanne L Parker, Saurabh Pandey, Fekade B Sime, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 3, 2011
Pharmacokinetic evaluation of fluconazole in critically ill patientsMahipal Sinnollareddy, Sandra L Peake, Michael S Roberts, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2014
Comparison of the accuracy and precision of pharmacokinetic equations to predict free meropenem concentrations in critically ill patientsGloria Wong, Andras Farkas, Rachel Sussman, et al.
International Journal of Antimicrobial Agents|July 26, 2015
Population pharmacokinetics and dosing simulations of cefepime in septic shock patients receiving continuous renal replacement therapyMieke Carlier, Fabio S Taccone, Majorie Beumier, et al.
Drug Discovery Today|January 18, 2019
Solid nanoparticles for oral antimicrobial drug delivery: a reviewAun Raza, Fekade Bruck Sime, Peter J Cabot, et al.
Expert Review of Clinical Pharmacology|May 29, 2019
Antibiotic exposure at the site of infection: principles and assessment of tissue penetrationNynke G L Jager, Reinier M van Hest, Jeffrey Lipman, et al.
Clinical Therapeutics|August 22, 2016
Uncertainty in Antibiotic Dosing in Critically Ill Neonate and Pediatric Patients: Can Microsampling Provide the Answers?Tavey Dorofaeff, Rossella M Bandini, Jeffrey Lipman, et al.
Pageof 69